Rejected at 4:37 p.m. Apr, 25, 2024 ] by Cameron
Author: jordan.phillips
Related Note: 1509300283162 1
Rationale for change

I tried to improve this card because the cloze is very difficult to guess because it is vague and has multiple possible answers.

Rejection reason

Think it's ok as is, info that it is reactivating an infection in this context should be enough to get to the cloze

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy



Watch Monoclonal Antibody Therapy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Cellular Injury and Neoplasia: Cell Cycle Independent Drug Targets

Watch associated Bootcamp video - Principles of Oncology and Therapeutics: Cell Cycle Independent Drug Targets

Watch associated Bootcamp video - Pharmacology : TNF-a Inhibitors and Monoclonal Antibodies
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::03_Kinase_Inhibitors_&_Monoclonal_Antibodies::02_Monoclonal_Antibody_Therapy #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::07_TNF_Alpha_Inhibitors_And_Monoclonal_Antibodies !AK_UpdateTags::Step1decks::Lolnotacop::Drugs #AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::19_Rituximab #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Rituximab #AK_Step1_v12::#OME::PreClinical::Immunology #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::05_Pharm::23_Rituximab #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#B&B::11_Hematology::04_Cancer_Drugs::06_Other_Cancer_Drugs #AK_Step1_v12::#FirstAid::10_Hematology_Oncology::05_Pharm::23_Rituximab::Rituximab